January 15, 2017 —CHARLOTTESVILLE, Va.—BrightSpec announced today the attainment of the CE Mark for the commercial sale in Europe of its BrightSpec ONE FT-MRR broadband spectrometer for trace gas analysis. CE Marking is a requirement for entering the European markets and certifies that the spectrometer conforms with a range of safety and engineering design standards.
BrightSpec worked with external CE Mark consultants for both for electromagnetic and for overall electrical safety standards, as reflected in the 2006/42/EC Machinery Directive and the 2014/30/EU EMC Directive. This is the third BrightSpec product to receive the CE Mark, after the Discovery and Broadband Chirality instruments, which first shipped to Europe in 2015. The recent certification was conducted in advance of shipping a BrightSpec ONE instrument to a large European R&D facility for two weeks of field trials.
BrightSpec Fourier transform molecular rotational resonance (FT-MRR) spectrometers enable high-resolution chemical analysis of small molecules in a complex mixture, without the need for chromatography. The BrightSpec ONE instrument is designed for pharmaceutical process R&D and advanced chemical manufacturing market segments.
BrightSpec builds the first commercial spectrometers and gas sensor based on millimeter and microwave spectroscopy techniques. The over existing spectroscopy techniques are the low level of sampling preconditioning required, the high spectral resolution and quantitative detection, and the ability to perform sophisticated structural analyses. BrightSpec instruments are in use at R&D facilities in the US and Europe, and build on the work of more than 100 academic and federal research groups. For more information, please contact Justin Neill, Chief Technology Officer, or Robert Lloyd, CEO at 434-202-2391, or visit www.brightspec.com